Pwodwi Entwodiksyon
| Triethyl orthoformate Enfòmasyon de baz |
| Non pwodwi: | Triethyl ortoformate |
| Sinonim: | 1,1',1''-[methylidynetris(oxy)]tris-Ethane;Ethane, 1,1',1''-[methylidynetris(oxy)]tris-;Ethane,1,1',1''- [methylidynetris(oxy)]tris-;Ethyl formate(ortho);1,1',1''-[methylidynetris(oxy)]tris-ethan;triethoxy-methan;Triethyl ester nan asid orthoformic;Triethylester kyseliny orthomravenci |
| CAS: | 122-51-0 |
| MF: | C7H16O3 |
| mw: | 148.2 |
| EINECS: | 204-550-4 |
| Kategori pwodwi: | Acetals/Ketals/Ortho Ester; Blòk Konstriksyon; Asid Amine; Sentèz Chimik; Blòk Konstriksyon òganik; Konpoze Oksijèn; Ortoestè; Sipleman Nitrisyonèl; ACS ak Solvang Klas Reyaktif; Boutèy an vè Amber; Bwat asye kabòn ak fil NPT; Reyaktif; sentèz; Solvang klas reyaktif; Solvang semi-bulk; Boutèy sòlvan; Solvan pa aplikasyon; Opsyon anbalaj sòlvan; Solvang; Solvang anidrid; Boutèy Sure/Seal;K00001;122-51-0;T0001 |
| Mol File: | 122-51-0.mol |
 |
|
| Triethyl orthoformate Pwopriyete Chimik |
| Pwen k ap fonn | -76 degre (lit.) |
| Pwen bouyi | 146 degre (lit.) |
| dansite | 0.891 g/mL nan 25 degre (lit.) |
| dansite vapè | 5.11 (kont lè) |
| presyon vapè | 2.9 mm Hg (20 degre) |
| endèks refraktif | n20/D 1.391(lit.) |
| Fp | 86 degre F |
| tanperati depo. | Zòn ki ka pran dife |
| solubilite | Chloroform (yon ti kras), Ethyl Acetate (yon ti kras), Methanol (yon ti kras) |
| fòm | Likid |
| koulè | Klè san koulè |
| Solibilite dlo | 1.35 g/L |
| Sansib | Imidite sansib |
| Merck | 14,6884 |
| BRN | 605384 |
| Estabilite: | Imidite sansib |
| InChiKey | GKASDNZWUGIAMG-UHFFFAOYSA-N |
| LogP | 1.2 nan 20 degre |
| Referans baz done CAS | 122-51-0(Referans baz done CAS) |
| Referans Chimi NIST | Ortoformiat etil (122-51-0) |
| Sistèm Rejis Sibstans EPA | Ortoformiat etil (122-51-0) |
| Enfòmasyon sou Sekirite |
| Kòd danje | ksi |
| Deklarasyon Risk | 10-36-36/38 |
| Deklarasyon Sekirite | 16-26-37/39-36-45-36/39 |
| RIDADR | UN 2524 3/PG 3 |
| WGK Almay | 1 |
| RTECS | RM6475000 |
| F | 21 |
| TSCA | Wi |
| HazardClass | 3 |
| PackingGroup | III |
| Kòd HS | 29159080 |
| Toksisite | LD50 oralman nan rat: 7.06 g/kg (Smyth) |
| Enfòmasyon MSDS |
| Founisè | Lang |
|---|---|
| Ortoformiat etil | angle |
| ACROS | angle |
| SigmaAldrich | angle |
| ALFA | angle |
| Triethyl orthoformate Itilizasyon ak sentèz |
| Pwopriyete chimik | Likid san koulè; odè pike. Trè ki ka pran dife. Yon ti kras idrosolubl nan dlo; idrosolubl nan alkòl, etè; dekonpoze nan dlo. |
| Itilizasyon | Ki make Prednisolone 21- Sulfat (P703755). Prednisolone 21-Sulfate se yon metabolit Prednisolone (P703740). |
| Itilizasyon | Yon reyaktif itil pou asetilizasyon ak fòmasyon ester imid. |
| Itilizasyon | Triethyl orthoformate yo itilize nan sentèz aldehyde Bodroux-Chichibabin pou prepare yon aldehyde ak yon sèl kabòn ki pi wo nan reyaji ak reyaktif Grignard. Li se tou itilize nan fòmilasyon elektwofil nan espès aromat aktive tankou fenol. |
| Deskripsyon jeneral | Yon likid klè, san koulè ak yon odè pike. Mwens dans pase dlo. Pwen flash 86 degre F. Vapè ki pi lou pase lè a. Ka irite po ak je. Yo itilize pou fè lòt pwodui chimik. |
| Pwofil Reyaktivite | Triethyl orthoformate se yon ester. Ester reyaji ak asid pou libere chalè ansanm ak alkòl ak asid. Asid oksidan fò ka lakòz yon reyaksyon wòdpòte ki ase ègzotèmik pou limen pwodwi reyaksyon yo. Chalè se tou ki te pwodwi pa entèraksyon an nan ester ak solisyon mordan. Idwojèn ki ka pran dife se pwodwi pa melanje ester ak metal alkali ak idr. |
| Danje | Ki ka pran dife, risk modere dife. |
| Danje Sante | Ka lakòz efè toksik si yo respire oswa absòbe nan po. Rale oswa kontak ak materyèl ka irite oswa boule po ak je. Dife pral pwodui gaz enèvan, korozivite ak/oswa toksik. Vapè yo ka lakòz vètij oswa toufe. Koule nan kontwòl dife oswa dlo dilution ka lakòz polisyon. |
| Danje dife | TRÈ FLAME: Yo pral fasilman limen ak chalè, etensèl oswa flanm dife. Vapè yo ka fòme melanj eksplozif ak lè a. Vapè yo ka vwayaje nan sous ignisyon epi retounen. Pifò vapè yo pi lou pase lè a. Yo pral gaye sou tè a epi kolekte nan zòn ki ba oswa ki fèmen (egou, sousòl, tank). Danje eksplozyon vapè andedan kay la, deyò oswa nan egou. Koule koule nan egou ka kreye danje dife oswa eksplozyon. Kontenè yo ka eksploze lè yo chofe. Anpil likid pi lejè pase dlo. |
| Enflamabilite ak eksplozibilite | Ki ka pran dife |
| Pwofil sekirite | Modere toksik pa enjèstyon. Mddly toksik pa rale, kontak po, ak wout anba lar. Yon irite po ak je. Yon danje dife trè danjere lè yo ekspoze a chalè oswa flanm dife; ka reyaji kouray ak materyèl oksidant. Pou konbat dife, sèvi ak kim, CO2, chimik sèk. Lè li chofe pou dekonpozisyon li emèt lafimen asid ak lafimen enèvan. Gade tou ESTERS. |
| Metòd pou pirifye | Fraksyone li an premye nan presyon atmosferik, answit nan yon vakyòm. Si li pa enpwòpte, lè sa a souke li ak NaOH akeuz 2%, seche l ak solid KOH epi distile li soti nan sodyòm nan yon kolòn Vigreux 20cm (p 11). Altènativman, lave l ak H2O, seche l sou K2CO3 anidrid, filtre ak fraksyon nan yon kolòn Widmer (p 11). [Sah & Ma J Am Chem Soc 54 2964 1932, Ohme & Schmitz Justus Liebigs Ann Chem 716 207 1968, Beilstein 2 IV 25.] IRITANTE ak FLAME. |
| Pwodwi preparasyon orthoformate triethyl ak matyè premyè |
| Matyè premyè | Ethanol-->Sodium-->Chloroform-->Sodium ethoxide-->Benzoyl chloride-->Solisyon etilat sodyòm, nan alkòl etilik |
| Preparasyon pwodwi yo | 3-(1,3,4-OXADIAZOL-2-YL)PYRIDINE-->1-CYCLOHEXYLURACIL-->METHYL 5-AMINOISOXAZOLE-4-CARBOXYLATE-->1-(4-METHYL-2-(METHYLTHIO)PYRIMIDIN-5-YL)ETHANONE-->4-Acetylphenylboronic acid-->4-AMINO-2-(ETHYLTHIO)-5-(HYDROXYMETHYL)PYRIMIDINE-->1-Cyclohexyl-1,2,3,4-tetrahydro-2,4-dioxopyrimidine-5-carbonitrile ,97%-->2-Formylfuran-5-boronic acid-->Estazolam-->2,4-DIAMINOPYRIMIDINE-5-CARBOXYLIC ACID-->4-Methylpyrimidine-->2-AMINO-3,5-DICYANOPYRIDINE-->ETHYL 4-HYDROXY-6-(TRIFLUOROMETHYL)QUINOLINE-3-CARBOXYLATE-->4(3H)-Pyrimidinone, 5-methyl-2-(methylthio)--->1-CHLORO-4-ISOCYANOBENZENE-->4, 6-DIHYDROXYNICOTINIC ACID ETHYL ESTER-->ETHYL 2-HYDROXY-4-PHENYLPYRIMIDINE-5-CARBOXYLATE-->2,4-DIAMINOPYRIMIDINE-5-CARBONITRILE-->Ethyl 4-amino-2-(ethylthio)-5-pyrimidinecarboxylate-->Ethyl 2-hydroxy-4-methyl-5-pyrimidinecarboxylate-->4-Chloro-7-(trifluoromethyl)quinoline-->4-HYDROXY-5,7-BIS-TRIFLUOROMETHYL-QUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER-->ETHYL 4-CHLORO-6-(TRIFLUOROMETHYL)-3-QUINOLINECARBOXYLATE-->2-HYDROXY-4-METHYLPYRIMIDINE-5-CARBOXYLIC ACID-->Diethoxymethyl acetate-->3-Aminopyrazole-4-carboxylic acid-->ETHYL 2-(ETHYLTHIO)-4-HYDROXYPYRIMIDINE-5-CARBOXYLATE-->5-AMINO-4-CARBETHOXY-1-PHENYLPYRAZOLE-->2-HYDROXY-4-PHENYLPYRIMIDINE-5-CARBOXYLIC ACID-->5-AMINO-1-PHENYLPYRAZOLE-4-CARBONITRILE-->ETHYL 3-(TRIFLUOROMETHYL)PYRAZOLE-4-CARBOXYLATE-->5-CARBETHOXYURACIL-->3-(2-FLUOROBENZYL)THIENO[2,3-D]PYRIMIDIN-4(3H)-ONE-->N-FORMYLGLYCINE ETHYL ESTER-->4-AMINO-2-(METHYLTHIO)PYRIMIDINE-5-CARBONITRILE-->2-AMINO-6-CHLORO-3,5-DICYANOPYRIDINE-->4,5-Dicyanoimidazole-->Chloromethyltriethoxysilane |
Baj popilè: triethyl orthoformate, Lachin triethyl orthoformate manifaktirè, Swèd, faktori
Pwochen: Trimethoxymethane
Ou ka renmen tou
Voye rechèch
